An In Vitro Comparison of Anti-Tumoral Potential of Wharton's Jelly and Bone Marrow Mesenchymal Stem Cells Exhibited by Cell Cycle Arrest in Glioma Cells (U87MG)

• Published in: Pathology oncology research Vol. 27; p. 584710
• Main Authors: Aslam, Nazneen, Abusharieh, Elham, Abuarqoub, Duaa, Alhattab, Dana, Jafar, Hanan, Alshaer, Walhan, Masad, Razan J, Awidi, Abdalla S
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media SA 08.04.2021; Frontiers Media S.A
• Subjects: Antineoplastic Agents - metabolism; Antineoplastic Agents - pharmacology; Apoptosis - drug effects; Blood-brain barrier; Bone marrow; Bone Marrow Cells - cytology; Bone Marrow Cells - metabolism; Brain cancer; Cancer therapies; Cell cycle; Cell Cycle Checkpoints - drug effects; Cell Movement - drug effects; Cell Proliferation - drug effects; Cells, Cultured; Culture Media, Conditioned - metabolism; Culture Media, Conditioned - pharmacology; Drug resistance; Fibroblasts; Fibroblasts - cytology; Fibroblasts - drug effects; Glioma; Glioma - pathology; Growth factors; Humans; Immune system; Kinases; Medical prognosis; Medical research; Mesenchymal Stem Cells - cytology; Mesenchymal Stem Cells - metabolism; Secretome - metabolism; Society Journal Archive; Stem cells; Wharton Jelly - cytology; Wharton Jelly - metabolism; United States > US; BM-MSC; cell lysate MSC-condition media; WJ-MSCs; glioblastoma; secretome; mesenchymal stem cells
• ISSN: 1532-2807; 1219-4956; 1532-2807
• DOI: 10.3389/pore.2021.584710

The therapeutic potential of mesenchymal stem cells (MSCs) for various malignancies is currently under investigation due to their unique properties. However, many discrepancies regarding their anti-tumoral or pro-tumoral properties have raised uncertainty about their application for anti-cancer therapies. To investigate, if the anti-tumoral or pro-tumoral properties are subjective to the type of MSCs under different experimental conditions we set out these experiments. Three treatments namely cell lysates (CL), serum-free conditioned media and FBS conditioned media (FBSCM) from each of Wharton's Jelly MSCs and Bone Marrow-MSCs were applied to evaluate the anti-tumoral or pro-tumoral effect on the glioma cells (U87MG). The functional analysis included; Morphological evaluation, proliferation and migration potential, cell cycle analysis, and apoptosis for glioma cells. The fibroblast cell line was added to investigate the stimulatory or inhibitory effect of treatments on the proliferation of the normal cell. We found that cell lysates induced a generalized inhibitory effect on the proliferation of the glioma cells and the fibroblasts from both types of MSCs. Similarly, both types of conditioned media from two types of MSCs exerted the same inhibitory effect on the proliferation of the glioma cells. However, the effect of two types of conditioned media on the proliferation of fibroblasts was stimulatory from BM-MSCs and variable from WJ-MSCs. Moreover, all three treatments exerted a likewise inhibitory effect on the migration potential of the glioma cells. Furthermore, we found that the cell cycle was arrested significantly at the G1 phase after treating cells with conditioned media which may have led to inhibit the proliferative and migratory abilities of the glioma cells (U87MG). We conclude that cell extracts of MSCs in the form of secretome can induce specific anti-tumoral properties in serum-free conditions for the glioma cells particularly the WJ-MSCs and the effect is mediated by the cell cycle arrest at the G1 phase.